Abstract
BackgroundT-Plex is an autologous TCR-T cell therapy product comprising customized combinations of 2–3 TCR-T cell components that recognize different tumor antigens presented on specific HLA class I molecules. Each component...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
